Import Biomedical Liquid Waste Treatment System Bml-48 — Buy in wholesale FOB from Supplier in India

The ECOKLIEN BML-48 is a biomedical liquid waste treatment system rated for up to 48 litres of hazardous effluent per day, targeting small to medium healthcare facilities that generate consistent volumes of infectious liquid waste. Like its stablemate, it combines electrocoagulation with electrooxidation in a hybrid reactor train designed to reduce pathogen load and chemical contaminant concentrations to levels acceptable for sewer discharge or further municipal treatment. The 48-litre daily capacity positions it between point-source mini units and larger centralised systems, suiting district hospitals, research institutes with multiple laboratories, and standalone diagnostic centres.

The treatment train relies on the same core electrochemical principles: electrocoagulation destabilises colloidal and emulsified waste components through sacrificial anode dissolution, while electrooxidation generates reactive species that mineralise recalcitrant organics and achieve disinfection. For a unit of this throughput, electrode surface area, current density, and hydraulic residence time must be balanced to avoid premature electrode exhaustion or incomplete oxidation. Standard industry practice for biomedical effluent of this scale typically employs aluminium or iron anodes with periodic polarity reversal to reduce passivation, though buyers should confirm the actual electrode specification and expected life in ampere-hours or litres treated per electrode set. The compact footprint referenced in the source suggests skid-mounted or floor-placed installation with minimal civil works.

Purchasers are likely to be hospital engineering departments, procurement consortia, and medical equipment dealers serving mid-tier healthcare markets. The BML-48 offers an alternative to costly third-party hazardous-waste collection contracts where transportation infrastructure is unreliable or regulatory scrutiny of off-site disposal is intensifying. As with the smaller BML-Mini, this listing does not specify binding MOQ, unit price, standard Incoterms, or confirmed lead time. Buyers should approach ECOKLIEN directly for quotation, request current ISO certification scope, and verify that the unit's output standards align with local environmental protection agency requirements for biomedical effluent in the destination country.

ECOKLIEN operates from 1/89, Ganapathy Nagar 1st St, Vengavasal, Chennai, Tamil Nadu 600126, India. The supplier is classified as organic tier with voyage trust tier within its marketplace profile. Notably, the response rate stands at 0.00 percent and average response hours at zero, which signals limited or unmonitored platform engagement. Prospective buyers should not rely solely on platform messaging; direct email, telephone, or third-party introduction is advisable to secure timely technical and commercial responses.

No disclosed profile information indicates founding date, ownership structure, number of employees, annual turnover, factory floor area, named domestic or international clients, or specific certifications held. The address places the company in the Chennai metropolitan area, a hub for medical device and precision engineering subcontracting, but this geographic proximity to industry clusters does not alone confirm manufacturing depth. Buyers are urged to request audited financial statements, visit the premises if feasible, and verify export experience through shipping-line references or customs-record checks before committing to volume orders.